For This AI Drug Developer, Look Beyond the Rally

Published by
The Street

By Maxx Chatsko Shares of Relay Therapeutics surged in late August. Durable rally or not, the future for this emerging biotech is bright. A handful of trendy biotech stocks in early August got swept up in meme-stock mania. Relay Therapeutics (RLAY) – Get Relay Therapeutics Inc. Report wasn’t one of them — but it still surged. The unheralded drug developer uses artificial intelligence, machine learning, and a supercomputer to design precision medicines. The biotech stock saw daily trading volume of roughly 1.5 million shares during the final full week of August. That isn’t much, but it was 50%…

Read More

See also  FEATURE: AI being employed to translate sign language to assist deaf in Japan

Leave a Reply